期刊文献+

用沙美特罗替卡松粉吸入剂治疗咳嗽变异型哮喘的效果观察 被引量:1

Observation on the effect of application of salmeterol-fluticasone powder in inhalation therapy on cough variant asthma
下载PDF
导出
摘要 目的:探讨用沙美特罗替卡松粉吸入剂治疗咳嗽变异型哮喘的临床效果。方法 :将2015年7月至2016年7月期间在蒲江县人民医院就诊的70例咳嗽变异型哮喘患者随机分为对照组和观察组(35例/组)。在两组患者住院期间,对对照组患者用复方甲氧那明胶囊进行治疗,对观察组患者用沙美特罗替卡松粉吸入剂进行治疗。在接受为期12周的治疗后,对比两组患者夜间咳嗽及胸闷气短等症状缓解的时间,同时比较接受治疗前后其动脉血气分析结果及咳嗽症状的积分。结果 :与对照组患者相比,观察组患者夜间咳嗽及胸闷气短缓解的时间均较短,P<0.05。在接受治疗前,两组患者的PH值、PaO_2、PaCO_2及咳嗽症状积分相比差异无统计学意义,P>0.05。在接受为期12周的治疗后,两组患者的PH值及PaO_2均高于接受治疗前,其PaCO_2及咳嗽症状积分均低于接受治疗前,而且观察组患者的PH值及PaO_2均高于对照组患者,其PaCO_2及咳嗽症状积分均低于对照组患者,P<0.05。结论 :用沙美特罗替卡松粉吸入剂治疗咳嗽变异型哮喘可显著缩短患者夜间咳嗽及胸闷气短等临床症状缓解的时间,改善其肺部的通气功能,纠正其酸碱失衡的状态,提升其治疗的效果。 Objective: To observe the effect of application of salmeterol-fluticasone powder in inhalation therapy on cough variant asthma. Methods: Divide 70 cases of cough variant asthma treated in Pujiang County People's Hospital during July 2015 to July 2016 to control group and experimental group(35 cases/group).During the patients hospitalization, treat control group with Compound Methoxyphenamine Capsules,treat experimental group with salmeterol-fluticasone powder inhalation therapy. After 12 weeks treatment, compare clinical symptoms response duration of 2 groups, then compare the results of arterial blood gas analysis and cough symptom integral before and after treatment. Results: Compare with control group, clinical symptoms response duration of experimental group is shorter than that in control group, P〈0.05. Before treatment, the difference of PH value,PaO2, PaCO2 and cough symptom integral of 2 groups have no statistical significant,P 0.05.After 12 weeks of treatment, PH value and PaO2 of 2 groups are all higher than that before, but PaCO2 and cough symptom integral are all lower than that before, and that PH value and PaO2 of experimental group are higher than that in control group, PaCO2 and cough symptom integral of experimental group are lower than that in control group, P〈0.05.Conclusion:Apply salmeterol-fluticasone powder in inhalation therapy on cough variant asthma will significantly shorten clinical symptoms response duration, and improve pulmonary function of the patients, it will correct acid-base imbalance, enhance effect of treatment.
作者 杨再春
机构地区 蒲江县人民医院
出处 《当代医药论丛》 2018年第1期24-26,共3页
关键词 复方甲氧那明胶囊 沙美特罗替卡松粉吸入剂 咳嗽变异型哮喘 Compound Methoxyphenamine Capsules salmeterol-fluticasone powder cough variant asthma
  • 相关文献

二级参考文献32

  • 1耿开兴,王若兵.支气管哮喘的八大危险因素[J].中国全科医学,2004,7(22):1693-1693. 被引量:6
  • 2李广勋.中药药理学与临床[M].天津:天津科技翻译出版社,1992:343.
  • 3阎锡新,杨红申,郭丽萍.支气管哮喘[M].北京:军事医学科学出版社,2007:231-244.
  • 4中华医学会呼吸病学分会哮喘学组.咳嗽的诊断与治疗指南(2009版)[J].中华结核和呼吸杂志,2009,3(2):407-413.
  • 5Niimi A. Cough and Asthma [ J ]. Current Respiratory Medicine Reviews, 2011, 7 (1): 47-54.
  • 6Tajiri T, Niimi A, Matsumoto H, et al. Prevalenee and clinical relevance of allergic rhinitis in patients with classic asthma and cough variant asthma [J]. Respiration, 2014, 87 (3): 211-218.
  • 7Ohta K, Yamaguehi M, Akiyama K, et al. Japanese guideline for adult asthma [J]. Allergol Int, 2011, 60 (2) : 115 -145.
  • 8Takemura M, Niimi A, Matsumoto H, et al. Clinical, physiological and anti - inflammatory effect of montelukast in patients with cough variant asthma [J]. Respiration, 2012, 83 (4): 308-315.
  • 9Okunishi K, Peters - Golden M. Leukotrienes and airway inflammation [J]. Biochimica Et Biophysica Acta, 2011, 1810 (11): 1096 - 1102.
  • 10Ohkura N, Fujimura M, Nakade Y, et al. Heightened cough response to bronchoconstriction in cough variant asthma [ J ]. Respirology, 2012, 17 (6): 964-968.

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部